Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Medicine and Dentistry
Iodine Deficiency
100%
Thyroid Nodule
56%
Urinary System
55%
Thyroid Gland
47%
Echography
35%
Sodium Chloride
30%
Prevalence
25%
Elastography
23%
Thyroid Disease
23%
Biological Marker
21%
Overall Survival
20%
Graves' Disease
17%
Antithyroid Agent
17%
Thyrotropin
17%
Goiter
17%
Cohort Effect
17%
Cancer
17%
Nodular Goiter
17%
Drug Therapy
17%
Thyroid Peroxidase Antibody
17%
Thyroid Antibody
17%
Thyroglobulin
17%
PARP Inhibitor
17%
Ovarian Cancer
17%
Homologous Recombination
17%
Protein Expression
17%
Pancreas Cancer
17%
Tumor
17%
Breast Cancer Resistance Protein
17%
Gemcitabine
17%
Esophageal Adenocarcinoma
17%
Chemotherapy
17%
Multivariate Analysis
13%
Progression Free Survival
12%
Ultrasound Elastography
11%
Randomized Clinical Trials
11%
Second Cancer
11%
Recurrent Disease
11%
Leukocyte
11%
Clinical Stage
11%
Prognostic Factor
11%
Preoperative Chemotherapy
11%
Urine Sampling
10%
Hormone Substitution
10%
Microcalcification
8%
Thyroid Incidentaloma
6%
Cancer Control
5%
Comorbidity
5%
Lymphocyte
5%
Cell Count
5%
Keyphrases
Iodine Fortification
33%
Graves Hyperthyroidism
23%
Iodine Intake
21%
Thyroglobulin
20%
Thyroid Disease
19%
Supplement Intake
17%
Incidental Thyroid Nodule
17%
Remission Induction
17%
Goiter
17%
TSH Receptor
17%
Orbitopathy
17%
Antithyroid Drugs
17%
Nodular Goiter
17%
Risk of Malignancy
17%
Bread
17%
Malignancy Marker
17%
Iodization
17%
Benign Thyroid Nodule
17%
Thyroid Malignancy
17%
Iodine Excretion
17%
Sustained Remission
17%
PARP Inhibitor Sensitivity
17%
Genetic Variants
17%
Homologous Recombination Deficiency
17%
Advanced Ovarian Cancer
17%
Perioperative Chemotherapy
17%
Transcriptomic Subtypes
17%
Aalborg
13%
Solitary Nodule
13%
PARP Inhibitor (PARPi)
13%
Downstaging
13%
Solid Nodule
8%
Autopsy Study
8%
Iodine-rich Food
8%
Total Fluid Intake
8%
Low Elasticity
8%
Sonographic
8%
Microcalcification
8%
Junctional Adenocarcinoma
8%
Median Progression-free Survival
8%
Treatment of Recurrence
8%
Anatomic Site
8%
Treatment Characteristics
8%
Copenhagen
7%
Thyroid Incidentaloma
7%
Iodine Deficiency
7%
Thyroid Nodule
7%
Hyperthyroidism
7%
Fortification Level
7%
Relapse Risk
6%
Pharmacology, Toxicology and Pharmaceutical Science
Graves Disease
53%
Antithyroid Agent
46%
Thyrotropin Receptor
27%
Remission
25%
Methimazole
21%
Biological Marker
20%
Thyrotropin
19%
Thyroglobulin
17%
Thyroid Antibody
17%
Iodine Deficiency
17%
Adverse Event
17%
Thyroid Peroxidase Antibody
17%
Ovary Cancer
17%
Adverse Drug Reaction
17%
Esophageal Adenocarcinoma
17%
Chemotherapy
17%
Goiter
17%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
17%
Pharmacotherapy
17%
Overall Survival
13%
Receptor Antibody
12%
Replacement Therapy
10%
Second Cancer
8%
Randomized Clinical Trial
8%
Comorbidity
8%
Recurrent Disease
8%
Progression Free Survival
7%
Neoplasm
5%
Oral Contraceptive Agent
5%
